NovaMed Tracks Global Regulatory Changes 5x Faster
NovaMed Pharmaceuticals
The Challenge
NovaMed Pharmaceuticals, with products approved in 30+ countries, faced a constant challenge: tracking regulatory announcements from the FDA, EMA, PMDA, and dozens of national health authorities simultaneously. Their regulatory affairs team of 12 spent the majority of each week combing government websites and industry publications in English, German, Japanese, and French — often discovering critical policy changes days after publication.
The Solution
ReadIntel's multilingual intelligence engine was configured to monitor regulatory bodies, health ministry publications, and pharmaceutical trade media across all of NovaMed's markets. AI-powered summarization distilled lengthy regulatory documents into actionable briefs, while automated alerts ensured the team was notified within minutes of any change affecting their active submissions or approved products.
The Results
Before ReadIntel, we discovered a critical labeling change in Japan three days after it was published. That kind of delay is unacceptable in pharma. Now we are alerted within the hour.
Ready to Write Your Success Story?
Join NovaMed Pharmaceuticals and other industry leaders who trust ReadIntel